$IMMX
Immix Biopharma, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Los Angeles, CA
IMMX chart
What traders are saying about $IMMX
Latest postsImmix Biopharma, Inc. news
- BlackRock reports a passive stake above 5% in Immix Biopharma (IMMX).
Stock Titan ·
- Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?
Yahoo Finance ·
- AL Amyloidosis Market is Projected to Boom by 2036 Owing to the Advancement of Targeted Therapies and Immunotherapies | DelveInsight
StreetInsider ·
- Immix Biopharma, Inc. Estimates – NASDAQ:IMMX
TradingView ·
- Immix Biopharma Stock Price Forecast. Should You Buy IMMX?
StockInvest.us ·
- Immix Biopharma (IMMX) Stock Sees Modest Fair Value Lift After Split Analyst Revisions
Yahoo Finance ·
- Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference
Yahoo Finance ·
- Immix Biopharma Reports 89% Complete Response in NXC-201 AL Amyloidosis Study
marketbeat.com ·
- Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock
Yahoo Finance ·
- BofA Raises Odds Of Success For Immix Biopharma’s NXC-201 Therapy — Sees Over 190% Upside In IMMX Stock
stocktwits.com ·
- Immix Biopharma Reports 89% Complete Response Rate in Phase 2 NXC-201 Trial
investorshub.advfn.com ·
- Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
Yahoo Finance ·
Immix Biopharma, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$29.4M | -$21.6M | -$15.4M | -$8.2M |
| Diluted EPS | $-0.89 | $-0.76 | $-0.89 | $-0.59 |
| Total assets (year end) | $104.8M | $22.9M | $19.9M | $14.9M |
| Cash and equivalents (year end) | $93.9M | $17.7M | $17.5M | $13.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Immix Biopharma, Inc.
- Ticker
- IMMX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Los Angeles, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1873835
- Former names
- Immix Biopharma, Inc.
Frequently asked questions
What exchange is Immix Biopharma, Inc. listed on?
Immix Biopharma, Inc. trades on the Nasdaq under the ticker symbol IMMX.
What industry is Immix Biopharma, Inc. in?
Immix Biopharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Immix Biopharma, Inc. headquartered?
Immix Biopharma, Inc.'s business address on file with the SEC is in Los Angeles, CA.
When does Immix Biopharma, Inc.'s fiscal year end?
Immix Biopharma, Inc.'s fiscal year ends on December 31.